Khazanah Buys Stake in Ipca, Regardless of FDA Query

Malaysia’s Khazanah Nasional Berhad invested approximately US$ 40 million for a small interest in Mumbai-based Ipca Laboratories Ltd. [ Content protected for Sovereign Wealth Fund Institute Standard subscribers only. Please subscribe to view content. ]

Contact the writer or creator of this article or page.
Questions or comments: support(at)swfinstitute(dot)org
Follow on Twitter at @swfinstitute and @sovereignfunds
Learn, Attend and Network: Institutional Investor Events and Summits
Go Back: HOME: Sovereign Wealth Fund Institute

institutional investor investment mandates